Inogen | INGN - Actif À Court Terme





Actif À Court Terme Changement Date
Abbott USD 26B 1.16B 2025-12
Accuray USD 303.6M 13.86M 2025-09
AngioDynamics USD 172.27M 3.09M 2025-02
Artivion USD 337.5M 18.68M 2025-09
AtriCure USD 322.52M 21.41M 2025-12
Baxter International USD 6.87B 61M 2025-12
Becton, Dickinson and Co. USD 9.19B 66M 2025-12
Boston Scientific USD 8.79B 759M 2025-12
Chart Industries USD 2.9B 40.5M 2025-12
Cooper Companies USD 2.11B 31.4M 2025-09
Dexcom USD 4.03B 1.19B 2025-12
Edwards Lifesciences USD 6.36B 218.3M 2025-09
Globus Medical USD 2.13B 201.25M 2025-12
Inogen USD 203.72M 594K 2025-09
Insulet USD 1.91B 54.6M 2025-12
Masimo USD 926M 122.3M 2025-12
Medtronic USD 24B 773M 2025-09
Orthofix International USD 394.17M 1.66M 2025-09
Philips EUR 9.93B 654M 2025-12
ResMed USD 3.82B 193.06M 2025-12
Steris USD 2.29B 179.9M 2025-12
Stryker USD 14.76B 1.04B 2025-12
Tandem Diabetes Care USD 618.14M 1.2M 2025-12
Teleflex USD 1.94B 47.65M 2025-12
X T L Biopharmaceuticals USD 533K 807K 2025-06
Zimmer Biomet Holdings USD 5.12B 715M 2025-12